S&T Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$116K Buy
1,916
+29
+2% +$1.69K 0.04% 125
2025
Q4
$102K Sell
1,887
-86
-4% -$4.14K 0.03% 134
2025
Q3
$89K Sell
1,973
-257
-12% -$12K 0.03% 144
2025
Q2
$103K Hold
2,230
0.03% 129
2025
Q1
$136K Buy
2,230
+343
+18% +$20K 0.04% 117
2024
Q4
$107K Buy
+1,887
New +$105K 0.03% 118

Other funds holding BMY

S&T Bank's BMY Position: Q1 2026 in Review

S&T Bank increased its Bristol-Myers Squibb (BMY) stake by 1.5% in Q1 2026, buying an estimated $1.69K and bringing the position to 1,916 shares worth $116K. The position accounts for 0.04% of the portfolio, ranked #125.

S&T Bank first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $136K in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • S&T Bank held 1,916 shares of Bristol-Myers Squibb worth $116K as of Q1 2026.
  • S&T Bank bought 29 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.69K.
  • Bristol-Myers Squibb made up 0.04% of S&T Bank's portfolio in Q1 2026, its #125 holding.
  • S&T Bank first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • S&T Bank's Bristol-Myers Squibb position peaked at $136K in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on S&T Bank's 13F filing for Q1 2026, filed 13 May 2026.